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Abstract: The chronic management of post-acute aortic dissection (AD) of the descending aorta 
(Type B) is based on optimal control of blood pressure (BP), with a target BP , 135/80 mmHg. 
The aim of our study was to determine and verify effective blood pressure control with an 
objective measurement method and to identify predicting factors.
Methods: We collected data from 26 patients hospitalized in the acute phase of a Type B AD 
between 2006 and 2009. Two groups were defined according to 24 hour BP monitoring results 
at follow-up. Group 1 consisted of patients with a controlled BP (,130/80 mmHg), and Group 2 
consisted of patients with an uncontrolled BP.
Results: Thirty four percent of patients showed an uncontrolled BP at checkup. Vascular 
history before AD (P = 0.06), high baseline BP trend (P = 0.01 for systolic and P = 0.08 for 
diastolic), and greater diameter of the descending aorta (P = 0.02) were associated with poor 
BP control.
Conclusion: Prognosis after AD is associated with BP control. Therefore, 24 hour BP 
  monitoring can be made.
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Introduction
Aortic dissection (AD), a component of the acute aortic syndrome, is a rare disease 
with a poor prognosis. Its estimated incidence falls between 0.5 and 2.95 cases per 
100,000 people per year.1–4  While Type A AD treatment is based on emergency surgery, 
treatment of Type B AD is essentially clinical with the combination of endovascular 
techniques in case of organ malperfusion or aortic rupture threat. Nevertheless, short- 
and mid-term prognosis of Type B AD is poor, with 10% intrahospital deaths5 and 25% 
mortality in the following 3 years, according to data from the International Registry 
of Aortic Dissection (IRAD).6
The management of these patients during the acute phase remains difficult, based 
primarily on blood pressure (BP) control and on treatment with analgesics. Chronic 
treatment is based on clinical and morphological monitoring of the aortic tree.   Optimal 
BP control is recommended for patients who have a history of AD (Type A or B) with a 
target systolic BP lower than 135 mmHg and a target diastolic BP lower than 80 mmHg. 
However, these values were arbitrarily determined and require   validation. The prognosis 
of these patients is associated with ectasia of the aorta and its   implications. BP control 
seems to be the main issue after such a vascular event, even more so because it concerns 
severely hypertensive patients and is often overlooked. There are few data on antihy-
pertensive   treatment.   Beta-blockers are the only type of drugs systematically used,7,8 Vascular Health and Risk Management 2012:8 submit your manuscript | www.dovepress.com
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although a combination of four to five antihypertensive drugs 
appears to be necessary to reach BP control.9 A recent update 
of the European recommendations on arterial hypertension 
stressed the importance of ambulatory   measures.10 These 
measures, including BP self-measurement and 24 hour 
monitoring, are common practice in the management of 
hypertension, but to our knowledge, no study has focused 
on these reliable methods of BP measuring in the particular 
context of AD.
The aim of this study was to ascertain the control of high 
BP in our population by an objective method of ambulatory 
BP measurement and to determine the predicting factors of 
poor BP control after a Type B AD.
Methods
Population
The data come from our local registry, comprising all patients 
hospitalized in the acute phase of an acute aortic dissection 
(AD [including intramural hematoma]) between 2006 and 
2009, and monitored in our center.
The management of all patients was identical. All patients 
were admitted to the Emergency Department in cardiac 
intensive care, and after hemodynamic stabilization and 
management of any vascular or general emergencies, they 
were transferred to the department of vascular medicine and 
arterial hypertension.
From November 2006 through April 2009, 26 patients 
consecutively hospitalized and monitored in our center to 
support an AD of the descending aorta were included in the 
study. In these patients, the AD etiology was atherosclerotic, 
except in two patients, who were known to present elastopathy 
before hospitalization.
Dissections of traumatic origin were not included in 
our study. An AD of the descending aorta was defined as 
not involving the ascending aorta. The acute nature was 
defined among those patients who were hospitalized within 
14 days of symptom onset.11 We distinguished between 
intramural hematoma and aortic dissections with throm-
bosed false lumen by the absence of an intimal flap or 
individualized entry point in case of parietal hematoma.12 
No patient with a penetrating aortic ulcer was included 
in the study.
Treatment of the acute phase
Medical management in the acute phase was based on 
antihypertensive treatment with a target systolic BP of 
120 mmHg, analgesic treatment, and management of vascular 
complications.
In cases of organ malperfusion, patients underwent 
endovascular revascularization such as aortic fenestration 
using the scissors technique13 or aortic stent, with or without 
a peripheral stent.14
Clinical malperfusion was defined as limb ischemia or 
mesenteric ischemia, and renal malperfusion was defined as 
acute renal failure and arterial hypertension not controlled by 
optimal medical treatment where acute renovascular etiology 
by static or hemodynamic malperfusion was suspected.
clinical data
Vascular history was assessed via coronary artery disease, 
peripheral arterial disease or stroke that had occurred before 
hospitalization. The history of aortic intervention was 
collected and included dissections and surgeries for aneu-
rysms of the abdominal or thoracic aorta. Data on classical 
cardiovascular risk factors and waist circumference were 
also collected. Abdominal obesity was defined as waist 
circumference greater than 102 cm for men and 88 cm for 
women. Patients were considered active smokers if they were 
currently smoking or had stopped during the three years prior 
to hospitalization.
Metabolic syndrome was defined according to the criteria 
set by the IDF (International Diabetes Federation), the AHA 
(American Heart Association) and the NHLBI (National Heart, 
Lung and Blood Institute) in 2009.15 Patients were considered 
to have metabolic syndrome if they presented at least three of 
the following five criteria: abdominal perimeter $102 cm for 
men or $88 cm for women; triglycerides .1.5 g/L or under 
treatment; HDL ,0.4 in men and ,0.5 in women; arterial 
pressure $130/80 mmHg or under treatment; and fasting 
glycemia $1.0 g/L.
The occurrence of an intrahospital cardiovascular event, 
such as myocardial infarction or stroke, was also recorded 
for each patient.
Blood pressure data
Upon admission to the intensive care unit, the first BP measure 
was recorded by the nurse. The BP at the patient’s discharge 
was the casual oscillatory BP measured by the nurse in the 
department of vascular medicine and arterial hypertension, 
before discharge. After the acute phase, all patients received 
24 hour BP monitoring with an adapted cuff. The equipment 
used was a Spacelabs Medical 90207 ambulatory blood pres-
sure monitor (Spacelabs Medical Ltd, Issaquah, WA). A BP 
measure was performed every 15 minutes. Daytime BP was 
measured between 6:00 am and 10:00 pm, and nighttime BP 
was measured between 10:00 pm and 6:00 am.Vascular Health and Risk Management 2012:8 submit your manuscript | www.dovepress.com
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The patients were divided into two groups according to 
the average 24 hour BP measured by monitoring. Group 1 
consisted of patients who had a systolic BP strictly below 
125 mmHg and a diastolic BP strictly below 80 mmHg. 
Group 2 consisted of patients who had a systolic BP greater 
than or equal to 125 mmHg and/or a diastolic BP greater 
than or equal to 80 mmHg.
Biological data
Renal function was assessed by estimating the glomerular 
filtration rate using the Modification of Diet in Renal Disease 
(MDRD) method, based on creatininemia measured on hos-
pital discharge day.16 Each patient underwent an exploration 
of lipid levels including LDL, HDL, and triglyceridemia.
Morphological data
Each patient had a CT or MRI angiography with injec-
tion before hospital discharge. The morphological data 
analyzed in this study was based on this reference exami-
nation performed at our center. The length of the ascend-
ing aorta was measured before the left pulmonary artery 
and perpendicular to the aortic arch. Measurement of the 
descending thoracic aorta was performed behind the right 
pulmonary artery. The aortic diameter was also measured 
at the diaphragm and subrenal aorta. Measurement of the 
false and true channel was done in a standardized manner, 
by taking the measure on a line perpendicular to the line 
of insertion of the intimal flap.17 Finally, extension of the 
dissection into a peripheral artery (gastrointestinal, renal, 
or iliac) was noted. This was defined as the identification of 
an intimal flap and two distinct lumens in an iliac, renal, or 
gastrointestinal artery.
Discharge treatment
Antihypertensive drug classes used in discharge treatment 
were recorded for each patient. The six classes used were 
inhibitors of the renin-angiotensin system (inhibitors of 
the angiotensin-converting enzyme and angiotensin II 
receptor antagonists), beta-blockers, diuretics (intake of 
thiazides or anti-aldosteronic drugs or both), calcium channel 
blockers, alpha-blockers, and central antihypertensive drugs. 
The number of antihypertensive drugs used (from different 
classes) was also recorded, defining a treatment score.
statistical methods
Statistical analyses were performed with SPSS software 
version 11.5 (IBM, Armonk, NY). Because the number of 
patients in each group was lower than 30, nonparametric tests 
were performed. Continuous variables were compared with 
the Mann–Whitney test, and categorical data were tested by 
Fisher’s exact test. Continuous variables were expressed as 
mean ± standard deviation. Categorical data were expressed 
as percent. The significance threshold was set at 0.05.
Results
Nine patients (34% of all patients) had poor BP control. 
Among the initial characteristics, BP control did not correlate 
with the patient’s age, gender, or body mass index. Only 
vascular history tended to be associated with poor BP control 
(P = 0.06). These results are summarized in Table 1.
BP measured upon admission did not affect future BP 
control, while BP measured casually at the patient’s discharge 
was correlated with poor BP control in the chronic phase 
(P = 0.017 for systolic BP and P = 0.088 for diastolic BP on 
discharge). Patients with a high BP trend at discharge were 
more likely to be poorly controlled (Table 2).
However, we noticed that at follow-up, the group of 
patients not controlled by monitoring presented both systolic 
and diastolic BP within the recommended discharge target 
values (124.4 mmHg and 70.6 mmHg, respectively).
The data resulting from 24 hour monitoring is shown in 
Table 3. There was a statistically significant difference in all 
parameters of the 24 hour monitoring (Figure 1).
All patients received a beta-blocker and an inhibitor of 
the renin-angiotensin system, so this parameter could not be 
analyzed. The patients received at least three antihypertensive 
drugs on discharge.
There was no difference between the different thera-
peutic classes used in each group, and there was a trend to 
use a greater number of antihypertensive drugs in the less 
controlled patients group (P = 0.07) (Table 4).
Concerning the morphological data of Type B AD, 
patients who had a smaller diaphragmatic aortic diameter and 
subrenal aortic diameter were better controlled (respectively 
P = 0.02 and P = 0.05) (Table 5). Other parameters, such as 
the diameter of the ascending aorta or the diameter of the 
false lumen, did not affect BP control. Similarly, no statisti-
cally significant difference was noted between intramural 
hematomas and AD.
Discussion
The aim of our study was to assess BP control after a Type B 
AD with a reliable measurement method and to identify 
potential predicting factors of poor BP control. Thirty four 
percent of our population was not at the recommended 
BP goal, and a minimum of three to four antihypertensive Vascular Health and Risk Management 2012:8 submit your manuscript | www.dovepress.com
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Table 2 clinical and biological data, hospital care
Overall population  
(n = 26)
Group 1 
Controlled BP  
(n = 19)
Group 2 
Uncontrolled patients  
(n = 7)
P-value
Clinical and biological data on admission
systolic blood pressure on admission (mmHg) 154.9 ± 29.4 155.5 ± 31.6 170.3 ± 33.6 0.24
Diastolic blood pressure on admission (mmHg) 71.7 ± 15.7 73.6 ± 18.9 78.9 ± 12.7 0.26
Heart rate on admission (bpm) 74.8 ± 12.2 76.2 ± 12.1 76.1 ± 15.5 0.11
MDRD clearance (Kg/ml/1.73 m²) 79.2 ± 23.0 72.3 ± 22.1 80.3 ± 18.7 0.48
HDL (g/L) 0.48 ± 0.15 0.44 ± 0.14 0.47 ± 0.11 0.74
LDL (g/L) 1.0 ± 0.38 1.11 ± 0.40 1.14 ± 0.33 0.91
Triglyceridemia (g/L) 1.1 ± 0.46 1.15 ± 0.56 1.00 ± 0.39 0.89
Intrahospital management
endovascular intervention (n, %) 9 (34.6) 7 (41.1) 2 (22.2) 0.34
cardiovascular events (n, %) 3 (11.5) 2 (11.7) 1 (11.1) 0.96
Pleural effusions (n, %) 5 (19.2) 5 (29.43) 0 (0) 0.07
MDRD clearance on discharge (Kg/ml/1.73 m²) 78.7 ± 23.9 69.1 ± 20.9 79.9 ± 23.7 0.36
sBP on discharge (mmHg) 116.1 ± 15.0 112.2 ± 10.8 124.4 ± 18.0 0.017
DBP on discharge (mmHg) 65.9 ± 10.3 64.8 ± 10.7 70.6 ± 8.0 0.088
Pulse pressure on discharge (mmHg) 50.4 ± 9.9 48.1 ± 6.7 53.9 ± 11.8 0.087
Heart rate on discharge (bpm) 67.3 ± 12.4 65.7 ± 13.6 71.1 ± 11.6 0.18
Abbreviations: MDRD, modification of diet in renal disease; HDL, high density lipoprotein; LDL, low density lipoprotein; SBP, systolic blood pressure; DBP, diastolic blood 
pressure.
Table 1 Population characteristics
Clinical and  
demographic data
Overall population  
n = 26
Group 1 
Controlled blood pressure  
(n = 17)
Group 2 
Uncontrolled blood pressure  
(n = 9)
P-value
Age (years) 62.7 ± 11.9 63.6 ± 10.9 68.0 ± 12.1 0.66
Male/female 24 (92.3) 15 (88.2) 9 (100) 0.53
Vascular history (n, %) 6 (23.1) 2 (11.7) 4 (44.4) 0.06
Aortic history (n, %) 3 (11.5) 3 (17.6) 0 (0) 0.19
cOPD (n, %) 3 (11.1) 1 (5.9) 2 (22.2) 0.22
elastopathy (n, %) 2 (7.7) 2 (11.7) 0 (0) 0.29
Cardiovascular risk factors
Hypertension (n, %) 19 (73.1) 11 (64.7) 8 (88.8) 0.19
smoking (n, %) 13 (50) 7 (41.1) 6 (66.6) 0.22
BMi (Kg/m²) 28.8 ± 6.7 27.8 ± 6.6 29.9 ± 12.6 0.86
Diabetes (n, %) 2 (7.7) 2 (11.7) 0 (0) 0.29
Dyslipidemia (n, %) 11 (42.3) 6 (35.3) 5 (55.5) 0.33
Abdominal obesity 
$88 cm if ♀, $102 cm if ♂
17 (65.4) 10 (58.8) 7 (77.7) 0.34
Metabolic syndrome (n, %)  
(iDF/AHA/nHLBi 2009)
15 (57.7) 8 (47.0) 7 (77.7) 0.13
Abbreviations: COPD, chronic obstructive pulmonary disease; BMI, body mass index.
  treatments seemed necessary before discharge. The patients 
at a higher risk of poor BP control were those who had a trend 
of high systolic and diastolic BP readings upon discharge. 
BP control in patients with Type B AD correlated statistically 
to the situation: vascular patients before hospitalization were 
likely to be less well controlled. Conversely, patients with 
smaller diaphragmatic and subrenal aortic diameter showed 
a better-controlled BP.
BP control after acute AD
While the negative influence of a high BP in the acute phase 
of a Type B AD has been presumed for a long time, the IRAD 
registry has only recently confirmed this hypothesis. From 
a population of 365 patients with Type B AD, persistent (or 
recurrent) chest pain and arterial hypertension (not controlled 
according to European recommendations) were independent 
predictors of total intrahospital mortality (17.4% vs 4%).18 Vascular Health and Risk Management 2012:8 submit your manuscript | www.dovepress.com
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Table 3 Blood pressure monitoring
Overall population  
n = 26
Group 1 
Controlled blood pressure  
(n = 19)
Group 2 
Uncontrolled blood pressure  
(n = 7)
P-value
24 hour sBP (mmHg) 123.0 ± 14.5 113.6 ± 8.6 141.0 ± 3.4 ,0.0001
24 hour DBP (mmHg) 70.1 ± 7.6 65.8 ± 5.4 78.6 ± 4.9 ,0.0001
24 hour PP (mmHg) 53.0 ± 9.3 47.9 ± 6.9 62.3 ± 5.8 ,0.0001
Daytime sBP (mmHg) 124.4 ± 14.3 115.4 ± 8.1 141.4 ± 4.7 ,0.0001
Daytime DBP (mmHg) 71.7 ± 7.7 67.7 ± 5.0 80.0 ± 5.6 ,0.0001
Daytime PP (mmHg) 52.7 ± 9.3 47.7 ± 6.7 61.4 ± 6.2 ,0.0001
nighttime sBP (mmHg) 120.5 ± 16.3 110.6 ± 11.4 140.3 ± 7.4 ,0.0001
nighttime DBP (mmHg) 67.0 ± 8.9 62.3 ± 7.1 75.9 ± 6.2 0.002
nighttime PP (mmHg) 54.3 ± 10.4 49.9 ± 9.4 64.7 ± 6.3 0.001
Abbreviations: SBP, systolic blood pressure; DBP, diastolic blood pressure; PP, pulse pressure.
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Figure 1 24 hour blood pressure difference between the two groups. group 1: 
patients reach blood pressure target; Group 2: uncontrolled patients.
Abbreviations:  SBP,  systolic  blood  pressure;  DBP,  diastolic  blood  pressure; 
PP, pulse pressure.
0
20
40
60
80
100
120
140
160
Global
population 
Group 1 G roup 2
Night-time SBP
Night-time DBP
Night-time PP
Figure 3 night-time BP difference between the two groups. group 1: patients reach 
blood pressure target; Group 2: uncontrolled patients.
Abbreviations:  SBP,  systolic  blood  pressure;  DBP,  diastolic  blood  pressure;   
PP, pulse pressure.
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Figure 2 Daytime BP difference between the two groups. group 1: patients reach 
blood pressure target; Group 2: uncontrolled patients.
Abbreviations:  SBP,  systolic  blood  pressure;  DBP,  diastolic  blood  pressure; 
PP, pulse pressure.
Strict BP control is an essential step in the management of 
these patients during the acute phase. However, little data 
has been reported on the proper control of BP during the 
chronic phase.
In our series, the diaphragmatic and subrenal aortic 
diameters were associated with BP control. Patients with a 
smaller diameter were better controlled. The benefits of BP 
decrease after dissection is assumed by the law of La Place, 
according to which the parietal tension of a vessel is the 
product of intravascular pressure and diameter. By lower-
ing the systemic BP, the risk of aneurysmal evolution of the 
aorta would also decrease. Our results suggest that poorly 
controlled patients are at risk of developing an aneurysmal 
complication.
24 hour BP monitoring after AD
In 2005, Eggebrecht reported that poor BP control was asso-
ciated with a younger age and a higher BMI in a population 
of 40 patients with chronic AD (38 patients suffered from 
Type B dissection, and two patients suffered from Type A 
dissection).9 This work was based on measurements repeated 
on three consecutive days. In this series, the need for at least 
five antihypertensive drugs in 75% of the patients was already 
noted. Our study is based on a more reliable assessment of 
BP by using 24 hour monitoring. However, our results do 
not confirm previous published results. Indeed, in our series, 
the BMI and level of abdominal obesity of patients had no 
influence on BP control, and poorly controlled patients were 
on average older (NS).
The simple measure of BP at discharge was   statistically 
associated with poor BP control in the chronic phase 
(P = 0.01 for systolic BP and 0.08 for diastolic BP). We 
noticed that the statistical significance was greater for 
systolic than for   diastolic BP. Pulse pressure at discharge Vascular Health and Risk Management 2012:8 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
28
Delsart et al
Table 5 Morphological data of Type B AD at discharge
Morphological data Overall population  
(n = 26)
Group 1 
Controlled blood pressure  
(n = 19)
Group 2 
Uncontrolled blood pressure  
(n = 7)
P-value
Diameter of the ascending aorta (mm) 37.1 ± 5.3 33.8 ± 3.5 40.0 ± 6.4 0.39
Diameter of the descending aorta (mm) 39.4 ± 5.7 41.4 ± 6.3 37.4 ± 2.9 0.10
True lumen: descending (mm) 20.6 ± 6.8 21.7 ± 7.4 19.5 ± 7.1 0.34
False lumen: descending (mm) 18.3 ± 6.8 19.4 ± 6.9 17.0 ± 6.1 0.90
Diameter of the diaphragmatic aorta (mm) 35.2 ± 5.8 33.9 ± 3.5 40.0 ± 6.4 0.02
subrenal aorta (mm) 26.2 ± 7.7 24.2 ± 4.4 30.2 ± 3.9 0.05
Dissected peripheral artery (n, %) 13 (50) 8 (47.0) 5 (55.5) 0.64
Abbreviation: AD, aortic dissection.
Table 4 Therapeutics and number of antihypertensive treatments on discharge
Discharge treatment Overall population  
(n = 26)
Group 1 
Controlled blood pressure  
(n = 17)
Group 2 
Uncontrolled blood pressure  
(n = 9)
P-value
PAA (n, %) 13 (50) 8 (47.0) 5 (55.5) 0.68
Acei/ARA2 (n, %) 26 (100) 17 (100) 9 (100) –
Beta-blockers 26 (100) 17 (100) 9 (100) –
calcium inhibitor (n, %) 23 (88.5) 15 (88.2) 8 (88.8) 0.96
statin (n, %) 15 (57.7) 9 (52.9) 6 (66.6) 0.51
VKA (n, %) 5 (19.2) 4 (23.5) 1 (11.1) 0.45
Diuretic (n, %) 17 (55.4) 9 (52.9) 8 (88.8) 0.07
number of antihypertensive 
drugs (different classes)
4.3 ± 0.9 4.2 ± 0.75 4.6 ± 0.96 0.07
Abbreviations:  PAA,  antiplatelet  agents;  ACEi,  angiotensin-converting  enzyme  inhibitors;  ARA2,  antagonists  of  the  angiotensin  receptor  Type  1  and  Type  2; 
VKA, vitamin K antagonist.
was almost significantly higher, and pulse pressure during 
the 24 hour monitoring was also greater (Figures 2 and 3). 
These elements suggested that poorly controlled patients 
might have a greater arterial   rigidity. This hypothesis 
is also supported by the fact that patients with vascular 
disease were already at risk of poor BP control. Arterial 
rigidity is known to be a risk marker for the development 
of cardiovascular diseases. This correlation underlines the 
importance of the cardiovascular field’s intervention. The 
main etiology of the dissection of the descending aorta 
was atherosclerosis.
Measuring BP upon discharge is insufficient when trying 
to estimate a BP control after an AD. Twenty-four hour BP 
monitoring appears to be a critical tool for the monitoring 
of these patients. It allows avoiding “masked” high arterial 
BP and the “white coat” effect that are only diagnosed with 
ambulatory measures. It is difficult to identify because it is 
associated with a target therapeutic BP on consultation and 
pathological values of ambulatory BP, making it hard to 
determine whether the patient needs to be treated.   Ambulatory 
measures are thus even more critical in this context, since 
poorly controlled patients had the target at-rest blood pressure 
before discharge. It seems legitimate to propose the ambulatory 
monitoring of BP, both to prevent the risk of a poor AD 
evolution (ectasia, evolution of the false lumen, extension of 
the dissection, aortic rupture) and for secondary cardiovascular   
prevention.
How to reach the blood pressure  
levels target
Thirty four percent of our population had an uncontrolled 
BP, despite antihypertensive treatment, with an average of 
five different antihypertensive classes used. This data is 
comparable to the Eggebrecht series of 2005,9 in which 40% 
of patients had resistant hypertension despite the combina-
tion of at least five antihypertensive drugs. In 1995, on this 
same population, Grajek19 showed that 75% of patients had 
resistant hypertension with an average grade 3, and those 
patients were then processed on average by 3.1 antihyper-
tensive drugs, of which only 10% received more than five 
antihypertensive drugs. This combination of antihypertensive 
drugs incremented under monitoring as suggested by the 
current guidelines on hypertension, appear to be a worthy 
strategy. One hundred percent of our patients were treated Vascular Health and Risk Management 2012:8 submit your manuscript | www.dovepress.com
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with beta-blockers and inhibitors of the renin-angiotensin 
system at hospital discharge and 88% of them were treated 
with a calcium channel blocker. Patients who presented with 
AD should be considered as patients with very high cardio-
vascular risk. The European recommendations state that these 
patients require at least an antihypertensive biotherapy (in 
addition to a specific beta-blocker therapy), and they advise 
to treat first with the combination of renin-angiotensin sys-
tem blockers with dihydropyridine, ideally in the form of a 
fixed combination for better adherence. If a complementary 
therapy is required, a thiazide diuretic should be added 
to the combination.20 In this regard, our data is consistent 
with the treatment strategy proposed by these latest recom-
mendations and confirm that at least three antihypertensive 
drugs are needed to control BP in hypertensive patients at 
very high cardiovascular risk. Nighttime blood pressure is 
also much higher in the group of poorly controlled patients, 
whereas it remained under 120/70 mmHg in the group of 
controlled patients. This supra physiologic notion of night-
time blood pressure should be considered for systemic search 
of sleep apnea syndrome in these patients. The prevalence of 
abdominal obesity and metabolic syndrome in our population 
encourages this approach. The prevalence of obesity in our 
population, as in the population described by Eggebrecht 
et al, reinforces the idea of establishing strong educational 
supports in addition to the drug strategy. This notion remains 
prioritary in the management of blood pressure, even if 
uncomplicated, and the management of obstructive sleep 
apnea syndrome.
The results of our study present several limitations. The 
low prevalence of AD and poor short-term prognosis could 
explain the limited size of our monocentric series. Because 
of its observational nature, we can only propose possible 
prognosis benefits. Data on the pre-hospital phase, such as 
duration and severity of hypertension, have not been taken 
into account. This work focused on measuring BP and did 
not take into account other parameters such as adherence to 
treatment, nor did we screen for secondary causes, such as 
sleep apnea syndrome. However, all patients were regularly 
followed-up at our practice, specializing in hypertension and 
vascular disease.
Conclusion
BP control is critical after an AD. A high BP and a very 
high cardiovascular risk are predictors of poor BP control. 
The prescription of a combination of different antihyperten-
sive drugs classes at discharge and the use of ambulatory 
measures could lead to an improvement of BP control and 
potentially improve the general and vascular prognosis of 
AD patients.
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